human recombinant factor VIII (Emergent BioSolutions)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namehuman recombinant factor VIII (Emergent BioSolutions)
Drug Alias Namehuman recombinant factor VIII (Cangene)human recombinant factor VIII (Inspiration Biopharmaceuticals)IB-1008
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionCoagulation factor VIII stimulants
TargetsCoagulation factor VIII
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInspiration Biopharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInspiration Biopharmaceuticals IncCangene CorpEmergent Biosolutions Inc
Active IndicationsN/A
Inactive IndicationsHemophilia A

Other Information

ATC CodeN/A
Related LinksN/A